South & Central America Microcarriers Market Forecast to 2030 - Regional Analysis - by Product (Media & Reagents and Microcarrier Beads), Equipment (Bioreactors, Culture Vessels, and Others), Application (Biopharmaceutical Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes)
The South & Central America microcarriers market is expected to grow from US$ 68.77 million in 2022 to US$ 129.96 million by 2030. It is estimated to register a CAGR of 8.3% from 2022 to 2030.
Automation of Cell and Gene Therapy Manufacturing Services Drives South & Central America Microcarriers Market
Incorporating automation in cell and gene therapy manufacturing would lead to a reduced risk of contamination, improved consistency, and decreased cost of production. Lonza Cocoon and the CliniMACS Prodigy system from Miltenyi are a few of the devices available in the market that have been designed to enable the automation of most sequential unit operations for a CAR-T process within a single system. The rising demand for cell and gene therapies has shifted production from a small-volume process to a large-volume process worldwide. The progress of cell and gene therapy from an academic and clinical setting to mass production and commercialization further propels the demand for automation in commercial manufacturing. Thus, automation is emerging as a new trend in the microcarriers market.
South & Central America Microcarriers Market Overview
The South & Central America microcarriers market is segmented into Brazil, Argentina, and the Rest of South & Central America. A surge in various research activities, rising healthcare expenditure, growing investments in biotechnology, burgeoning incidences of infectious diseases, and government efforts to promote the utilization of immobilized cell culture media to ease the healthcare processes are major factors contributing to the growth of the market. According to a report titled "First Gene Therapy Products Approved in Brazil," published by Law Business Research 2020, Brazil is among the first Latin American countries to approve the marketing of gene therapy products. The Brazilian Health Regulatory Agency (ANVISA) has granted marketing authorization for Novartis' gene therapy products-Luxturna and Zolgensma. Both products were approved by the Brazilian Technical Commission of Biosafety (CTNBio), which is responsible for evaluating the biosafety of genetically modified organisms in Brazil. In September 2021, Sorrento Therapeutics began subject enrolment in the Phase II clinical trial of human allogeneic adipose-derived mesenchymal stem cells (COVI-MSC) for treating COVID-19 patients with acute respiratory distress syndrome (ARDS) or acute respiratory distress (ARD) in Brazil. Thus, such advancements in cell therapy boost the growth of the microcarriers market in Brazil.
South & Central America Microcarriers Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Microcarriers Market Segmentation
The South & Central America microcarriers market is segmented into product, equipment, application, end user, and country.
Based on product, the South & Central America microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held a larger share of the South & Central America microcarriers market in 2022.
In terms of equipment, the South & Central America microcarriers market is segmented into bioreactors, culture vessels, and others. The bioreactors segment held the largest share of the South & Central America microcarriers market in 2022.
Based on application, the South & Central America microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production segment held the largest share of the South & Central America microcarriers market in 2022. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.
Based on end user, the North America microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held the largest share of the North America microcarriers market in 2022.
Based on country, the South & Central America microcarriers market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America microcarriers market in 2022.
Bio-Rad Laboratories Inc, Sartorius AG, Danaher Corp, Eppendorf SE, Asahi Kasei Corp, and Polysciences Inc are some of the leading companies operating in the South & Central America microcarriers market.
Automation of Cell and Gene Therapy Manufacturing Services Drives South & Central America Microcarriers Market
Incorporating automation in cell and gene therapy manufacturing would lead to a reduced risk of contamination, improved consistency, and decreased cost of production. Lonza Cocoon and the CliniMACS Prodigy system from Miltenyi are a few of the devices available in the market that have been designed to enable the automation of most sequential unit operations for a CAR-T process within a single system. The rising demand for cell and gene therapies has shifted production from a small-volume process to a large-volume process worldwide. The progress of cell and gene therapy from an academic and clinical setting to mass production and commercialization further propels the demand for automation in commercial manufacturing. Thus, automation is emerging as a new trend in the microcarriers market.
South & Central America Microcarriers Market Overview
The South & Central America microcarriers market is segmented into Brazil, Argentina, and the Rest of South & Central America. A surge in various research activities, rising healthcare expenditure, growing investments in biotechnology, burgeoning incidences of infectious diseases, and government efforts to promote the utilization of immobilized cell culture media to ease the healthcare processes are major factors contributing to the growth of the market. According to a report titled "First Gene Therapy Products Approved in Brazil," published by Law Business Research 2020, Brazil is among the first Latin American countries to approve the marketing of gene therapy products. The Brazilian Health Regulatory Agency (ANVISA) has granted marketing authorization for Novartis' gene therapy products-Luxturna and Zolgensma. Both products were approved by the Brazilian Technical Commission of Biosafety (CTNBio), which is responsible for evaluating the biosafety of genetically modified organisms in Brazil. In September 2021, Sorrento Therapeutics began subject enrolment in the Phase II clinical trial of human allogeneic adipose-derived mesenchymal stem cells (COVI-MSC) for treating COVID-19 patients with acute respiratory distress syndrome (ARDS) or acute respiratory distress (ARD) in Brazil. Thus, such advancements in cell therapy boost the growth of the microcarriers market in Brazil.
South & Central America Microcarriers Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Microcarriers Market Segmentation
The South & Central America microcarriers market is segmented into product, equipment, application, end user, and country.
Based on product, the South & Central America microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held a larger share of the South & Central America microcarriers market in 2022.
In terms of equipment, the South & Central America microcarriers market is segmented into bioreactors, culture vessels, and others. The bioreactors segment held the largest share of the South & Central America microcarriers market in 2022.
Based on application, the South & Central America microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production segment held the largest share of the South & Central America microcarriers market in 2022. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.
Based on end user, the North America microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held the largest share of the North America microcarriers market in 2022.
Based on country, the South & Central America microcarriers market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America microcarriers market in 2022.
Bio-Rad Laboratories Inc, Sartorius AG, Danaher Corp, Eppendorf SE, Asahi Kasei Corp, and Polysciences Inc are some of the leading companies operating in the South & Central America microcarriers market.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SOUTH & CENTRAL AMERICA MICROCARRIERS MARKET - KEY INDUSTRY DYNAMICS
4.1 Key Market Drivers:
4.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
4.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
4.1.3 Surge in Adoption of Regenerative Medicine
4.2 Market Restraints
4.2.1 High Cost of Biologics and Cell-based Therapies
4.3 Market Opportunities
4.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers
4.4 Future Trends
4.4.1 Automation of Cell and Gene Therapy Manufacturing Services
4.5 Impact Analysis
5. MICROCARRIERS MARKET - SOUTH & CENTRAL AMERICA MARKET ANALYSIS
5.1 Microcarriers Market Revenue (US$ Mn), 2022 - 2030
6. SOUTH & CENTRAL AMERICA MICROCARRIERS MARKET - REVENUE AND FORECAST TO 2030 - BY PRODUCT
6.1 Overview
6.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Microcarrier Beads
6.3.1 Overview
6.3.2 Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Media and Reagents
6.4.1 Overview
6.4.2 Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
7. SOUTH & CENTRAL AMERICA MICROCARRIERS MARKET - REVENUE AND FORECAST TO 2030 - BY EQUIPMENT
7.1 Overview
7.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
7.3 Bioreactors
7.3.1 Overview
7.3.2 Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Culture Vessels
7.4.1 Overview
7.4.2 Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
8. SOUTH & CENTRAL AMERICA MICROCARRIERS MARKET - REVENUE AND FORECAST TO 2030 - BY APPLICATION
8.1 Overview
8.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Biopharmaceutical Production
8.3.1 Overview
8.3.2 Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
8.3.3 Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
8.3.4 Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Cell and Gene Therapy
8.4.1 Overview
8.4.2 Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Tissue Engineering and Regenerative Medicine
8.5.1 Overview
8.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
9. SOUTH & CENTRAL AMERICA MICROCARRIERS MARKET REVENUE AND FORECASTS TO 2030 - END USER
9.1 Overview
9.2 South & Central America Microcarriers Market Share by End User - 2022 & 2030 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market- Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Research Organizations and Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
10. SOUTH & CENTRAL AMERICA MICROCARRIERS MARKET REVENUE AND FORECASTS TO 2030 -COUNTRY ANALYSIS
10.1 South & Central America Microcarriers Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 South & Central America: Microcarriers Market, by Country
10.1.2.1 Brazil
10.1.2.1.1 Overview
10.1.2.1.2 Brazil: Microcarriers Market Revenue and Forecast to 2030 (BRAZIL$ Mn)
10.1.2.1.3 Brazil: Microcarriers Market, by Product
10.1.2.1.4 Brazil: Microcarriers Market, by Equipment
10.1.2.1.5 Brazil: Microcarriers Market, by Application
10.1.2.1.5.1 Brazil: Microcarriers Market, by Biopharmaceutical Production
10.1.2.1.6 Brazil: Microcarriers Market, by End User
10.1.2.2 Argentina
10.1.2.2.1 Overview
10.1.2.2.2 Argentina: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.3 Argentina: Microcarriers Market, by Product
10.1.2.2.4 Argentina: Microcarriers Market, by Equipment
10.1.2.2.5 Argentina: Microcarriers Market, by Application
10.1.2.2.5.1 Argentina: Microcarriers Market, by Biopharmaceutical Production
10.1.2.2.6 Argentina: Microcarriers Market, by End User
10.1.2.3 Rest Of South & Central America
10.1.2.3.1 Overview
10.1.2.3.2 Rest Of South & Central America: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.3.3 Rest Of South & Central America: Microcarriers Market, by Product
10.1.2.3.4 Rest Of South & Central America: Microcarriers Market, by Equipment
10.1.2.3.5 Rest of South & Central America: Microcarriers Market, by Application
10.1.2.3.5.1 Rest Of South & Central America: Microcarriers Market, by Biopharmaceutical Production
10.1.2.3.6 Rest Of South & Central America: Microcarriers Market, by End User
11. MICROCARRIERS MARKET-INDUSTRY LANDSCAPE
11.1 Overview
11.2 Organic Growth Strategies
11.2.1 Overview
11.3 Inorganic Growth Strategies
11.3.1 Overview
12. COMPANY PROFILES
12.1 Bio-Rad Laboratories Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sartorius AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Danaher Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Eppendorf SE
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Asahi Kasei Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Polysciences Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. APPENDIX
13.1 About the Insight Partners
13.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SOUTH & CENTRAL AMERICA MICROCARRIERS MARKET - KEY INDUSTRY DYNAMICS
4.1 Key Market Drivers:
4.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
4.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
4.1.3 Surge in Adoption of Regenerative Medicine
4.2 Market Restraints
4.2.1 High Cost of Biologics and Cell-based Therapies
4.3 Market Opportunities
4.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers
4.4 Future Trends
4.4.1 Automation of Cell and Gene Therapy Manufacturing Services
4.5 Impact Analysis
5. MICROCARRIERS MARKET - SOUTH & CENTRAL AMERICA MARKET ANALYSIS
5.1 Microcarriers Market Revenue (US$ Mn), 2022 - 2030
6. SOUTH & CENTRAL AMERICA MICROCARRIERS MARKET - REVENUE AND FORECAST TO 2030 - BY PRODUCT
6.1 Overview
6.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Microcarrier Beads
6.3.1 Overview
6.3.2 Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Media and Reagents
6.4.1 Overview
6.4.2 Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
7. SOUTH & CENTRAL AMERICA MICROCARRIERS MARKET - REVENUE AND FORECAST TO 2030 - BY EQUIPMENT
7.1 Overview
7.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
7.3 Bioreactors
7.3.1 Overview
7.3.2 Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Culture Vessels
7.4.1 Overview
7.4.2 Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
8. SOUTH & CENTRAL AMERICA MICROCARRIERS MARKET - REVENUE AND FORECAST TO 2030 - BY APPLICATION
8.1 Overview
8.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Biopharmaceutical Production
8.3.1 Overview
8.3.2 Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
8.3.3 Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
8.3.4 Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Cell and Gene Therapy
8.4.1 Overview
8.4.2 Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Tissue Engineering and Regenerative Medicine
8.5.1 Overview
8.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
9. SOUTH & CENTRAL AMERICA MICROCARRIERS MARKET REVENUE AND FORECASTS TO 2030 - END USER
9.1 Overview
9.2 South & Central America Microcarriers Market Share by End User - 2022 & 2030 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market- Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Research Organizations and Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
10. SOUTH & CENTRAL AMERICA MICROCARRIERS MARKET REVENUE AND FORECASTS TO 2030 -COUNTRY ANALYSIS
10.1 South & Central America Microcarriers Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 South & Central America: Microcarriers Market, by Country
10.1.2.1 Brazil
10.1.2.1.1 Overview
10.1.2.1.2 Brazil: Microcarriers Market Revenue and Forecast to 2030 (BRAZIL$ Mn)
10.1.2.1.3 Brazil: Microcarriers Market, by Product
10.1.2.1.4 Brazil: Microcarriers Market, by Equipment
10.1.2.1.5 Brazil: Microcarriers Market, by Application
10.1.2.1.5.1 Brazil: Microcarriers Market, by Biopharmaceutical Production
10.1.2.1.6 Brazil: Microcarriers Market, by End User
10.1.2.2 Argentina
10.1.2.2.1 Overview
10.1.2.2.2 Argentina: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.2.3 Argentina: Microcarriers Market, by Product
10.1.2.2.4 Argentina: Microcarriers Market, by Equipment
10.1.2.2.5 Argentina: Microcarriers Market, by Application
10.1.2.2.5.1 Argentina: Microcarriers Market, by Biopharmaceutical Production
10.1.2.2.6 Argentina: Microcarriers Market, by End User
10.1.2.3 Rest Of South & Central America
10.1.2.3.1 Overview
10.1.2.3.2 Rest Of South & Central America: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
10.1.2.3.3 Rest Of South & Central America: Microcarriers Market, by Product
10.1.2.3.4 Rest Of South & Central America: Microcarriers Market, by Equipment
10.1.2.3.5 Rest of South & Central America: Microcarriers Market, by Application
10.1.2.3.5.1 Rest Of South & Central America: Microcarriers Market, by Biopharmaceutical Production
10.1.2.3.6 Rest Of South & Central America: Microcarriers Market, by End User
11. MICROCARRIERS MARKET-INDUSTRY LANDSCAPE
11.1 Overview
11.2 Organic Growth Strategies
11.2.1 Overview
11.3 Inorganic Growth Strategies
11.3.1 Overview
12. COMPANY PROFILES
12.1 Bio-Rad Laboratories Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sartorius AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Danaher Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Eppendorf SE
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Asahi Kasei Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Polysciences Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. APPENDIX
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Microcarriers Market Segmentation
Table 2. Brazil Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
Table 3. Brazil Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
Table 4. Brazil Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
Table 5. Brazil Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
Table 6. Brazil: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
Table 7. Argentina Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
Table 8. Argentina Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
Table 9. Argentina Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
Table 10. Argentina Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
Table 11. Argentina: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
Table 12. Rest Of South & Central America Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
Table 13. Rest Of South & Central America Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
Table 14. Rest Of South & Central America Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
Table 15. Rest Of South & Central America Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
Table 16. Rest Of South & Central America: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
Table 17. Recent Organic Growth Strategies in Microcarriers Market
Table 18. Recent Inorganic Growth Strategies in the Microcarriers Market
Table 19. Glossary of Terms
Table 1. Microcarriers Market Segmentation
Table 2. Brazil Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
Table 3. Brazil Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
Table 4. Brazil Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
Table 5. Brazil Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
Table 6. Brazil: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
Table 7. Argentina Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
Table 8. Argentina Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
Table 9. Argentina Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
Table 10. Argentina Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
Table 11. Argentina: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
Table 12. Rest Of South & Central America Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
Table 13. Rest Of South & Central America Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
Table 14. Rest Of South & Central America Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
Table 15. Rest Of South & Central America Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
Table 16. Rest Of South & Central America: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
Table 17. Recent Organic Growth Strategies in Microcarriers Market
Table 18. Recent Inorganic Growth Strategies in the Microcarriers Market
Table 19. Glossary of Terms
